{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T18:28:06Z","timestamp":1742927286632,"version":"3.40.3"},"publisher-location":"Cham","reference-count":126,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783031230578"},{"type":"electronic","value":"9783031230585"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/7854_2022_392","type":"book-chapter","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T07:03:14Z","timestamp":1664434994000},"page":"203-228","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Role of Dopamine D3 Receptors in Tobacco Use Disorder: A Synthesis of the Preclinical and Clinical Literature"],"prefix":"10.1007","author":[{"given":"Kevin","family":"Butler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Le Foll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Di Ciano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,30]]},"reference":[{"issue":"3","key":"392_CR1","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.bbrc.2019.05.020","volume":"514","author":"S Acharya","year":"2019","unstructured":"Acharya S, Kim KM (2019) \u03b14\u03b22 nicotinic acetylcholine receptor downregulates D(3) dopamine receptor expression through protein kinase C activation. Biochem Biophys Res Commun 514(3):665\u2013671. https:\/\/doi.org\/10.1016\/j.bbrc.2019.05.020","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"392_CR2","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1111\/add.12941","volume":"110","author":"SA Agboola","year":"2015","unstructured":"Agboola SA, Coleman T, McNeill A, Leonardi-Bee J (2015) Abstinence and relapse among smokers who use varenicline in a quit attempt-a pooled analysis of randomized controlled trials. Addiction 110(7):1182\u20131193. https:\/\/doi.org\/10.1111\/add.12941","journal-title":"Addiction"},{"issue":"3","key":"392_CR3","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s11682-013-9233-4","volume":"7","author":"DS Albrecht","year":"2013","unstructured":"Albrecht DS, Kareken DA, Yoder KK (2013) Effects of smoking on D2\/D3 striatal receptor availability in alcoholics and social drinkers. Brain Imaging Behav 7(3):326\u2013334. https:\/\/doi.org\/10.1007\/s11682-013-9233-4","journal-title":"Brain Imaging Behav"},{"key":"392_CR4","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders: DSM-5","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders: DSM-5. American Psychiatric Association, Arlington"},{"issue":"7","key":"392_CR5","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/sj.npp.1300183","volume":"28","author":"M Andreoli","year":"2003","unstructured":"Andreoli M, Tessari M, Pilla M, Valerio E, Hagan JJ, Heidbreder CA (2003) Selective antagonism at dopamine D3 receptors prevents nicotine-triggered relapse to nicotine-seeking behavior. Neuropsychopharmacology 28(7):1272\u20131280. https:\/\/doi.org\/10.1038\/sj.npp.1300183","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"392_CR6","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/bcp.12116","volume":"77","author":"HJ Aubin","year":"2014","unstructured":"Aubin HJ, Luquiens A, Berlin I (2014) Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice. Br J Clin Pharmacol 77(2):324\u2013336. https:\/\/doi.org\/10.1111\/bcp.12116","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"392_CR7","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1523\/jneurosci.2225-15.2016","volume":"36","author":"MM Barrus","year":"2016","unstructured":"Barrus MM, Winstanley CA (2016) Dopamine D3 receptors modulate the ability of win-paired cues to increase risky choice in a rat gambling task. J Neurosci 36(3):785\u2013794. https:\/\/doi.org\/10.1523\/jneurosci.2225-15.2016","journal-title":"J Neurosci"},{"issue":"7","key":"392_CR8","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.biopsych.2010.07.014","volume":"69","author":"G Bedi","year":"2011","unstructured":"Bedi G, Preston KL, Epstein DH, Heishman SJ, Marrone GF, Shaham Y, de Wit H (2011) Incubation of cue-induced cigarette craving during abstinence in human smokers. Biol Psychiatry 69(7):708\u2013711. https:\/\/doi.org\/10.1016\/j.biopsych.2010.07.014","journal-title":"Biol Psychiatry"},{"issue":"24","key":"392_CR9","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMra0809890","volume":"362","author":"NL Benowitz","year":"2010","unstructured":"Benowitz NL (2010) Nicotine addiction. N Engl J Med 362(24):2295\u20132303. https:\/\/doi.org\/10.1056\/NEJMra0809890","journal-title":"N Engl J Med"},{"issue":"3","key":"392_CR10","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00213-006-0578-x","volume":"191","author":"KC Berridge","year":"2007","unstructured":"Berridge KC (2007) The debate over dopamine's role in reward: the case for incentive salience. Psychopharmacology (Berl) 191(3):391\u2013431. https:\/\/doi.org\/10.1007\/s00213-006-0578-x","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"392_CR11","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1523\/JNEUROSCI.4371-11.2012","volume":"32","author":"I Boileau","year":"2012","unstructured":"Boileau I, Payer D, Houle S, Behzadi A, Rusjan PM, Tong J et al (2012) Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study. J Neurosci 32(4):1353\u20131359. https:\/\/doi.org\/10.1523\/JNEUROSCI.4371-11.2012","journal-title":"J Neurosci"},{"issue":"5","key":"392_CR12","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1111\/add.12066","volume":"108","author":"I Boileau","year":"2013","unstructured":"Boileau I, Payer D, Chugani B, Lobo D, Behzadi A, Rusjan PM et al (2013) The D2\/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride. Addiction 108(5):953\u2013963. https:\/\/doi.org\/10.1111\/add.12066","journal-title":"Addiction"},{"issue":"9","key":"392_CR13","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1016\/j.euroneuro.2015.06.002","volume":"25","author":"I Boileau","year":"2015","unstructured":"Boileau I, Nakajima S, Payer D (2015) Imaging the D3 dopamine receptor across behavioral and drug addictions: positron emission tomography studies with [(11)C]-(+)-PHNO. Eur Neuropsychopharmacol 25(9):1410\u20131420. https:\/\/doi.org\/10.1016\/j.euroneuro.2015.06.002","journal-title":"Eur Neuropsychopharmacol"},{"issue":"13","key":"392_CR14","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1038\/npp.2016.108","volume":"41","author":"I Boileau","year":"2016","unstructured":"Boileau I, Payer D, Rusjan PM, Houle S, Tong J, McCluskey T et al (2016) Heightened dopaminergic response to amphetamine at the D3 dopamine receptor in methamphetamine users. Neuropsychopharmacology 41(13):2994\u20133002. https:\/\/doi.org\/10.1038\/npp.2016.108","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"392_CR15","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s00213-008-1341-2","volume":"202","author":"V Boulougouris","year":"2009","unstructured":"Boulougouris V, Casta\u00f1\u00e9 A, Robbins TW (2009) Dopamine D2\/D3 receptor agonist quinpirole impairs spatial reversal learning in rats: investigation of D3 receptor involvement in persistent behavior. Psychopharmacology (Berl) 202(4):611\u2013620. https:\/\/doi.org\/10.1007\/s00213-008-1341-2","journal-title":"Psychopharmacology (Berl)"},{"issue":"7","key":"392_CR16","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1176\/appi.ajp.161.7.1211","volume":"161","author":"AL Brody","year":"2004","unstructured":"Brody AL, Olmstead RE, London ED, Farahi J, Meyer JH, Grossman P et al (2004) Smoking-induced ventral striatum dopamine release. Am J Psychiatry 161(7):1211\u20131218. https:\/\/doi.org\/10.1176\/appi.ajp.161.7.1211","journal-title":"Am J Psychiatry"},{"issue":"5","key":"392_CR17","doi-asserted-by":"publisher","first-page":"e36781","DOI":"10.1371\/journal.pone.0036781","volume":"7","author":"N Broos","year":"2012","unstructured":"Broos N, Schmaal L, Wiskerke J, Kostelijk L, Lam T, Stoop N et al (2012) The relationship between impulsive choice and impulsive action: a cross-species translational study. PLoS One 7(5):e36781. https:\/\/doi.org\/10.1371\/journal.pone.0036781","journal-title":"PLoS One"},{"issue":"7","key":"392_CR18","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1017\/s1461145711001957","volume":"15","author":"AK Brown","year":"2012","unstructured":"Brown AK, Mandelkern MA, Farahi J, Robertson C, Ghahremani DG, Sumerel B et al (2012) Sex differences in striatal dopamine D2\/D3 receptor availability in smokers and non-smokers. Int J Neuropsychopharmacol 15(7):989\u2013994. https:\/\/doi.org\/10.1017\/s1461145711001957","journal-title":"Int J Neuropsychopharmacol"},{"key":"392_CR19","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3389\/fpsyt.2019.00098","volume":"10","author":"K Butler","year":"2019","unstructured":"Butler K, Le Foll B (2019) Impact of substance use disorder pharmacotherapy on executive function: a narrative review. Front Psych 10:98. https:\/\/doi.org\/10.3389\/fpsyt.2019.00098","journal-title":"Front Psych"},{"issue":"4\u20135","key":"392_CR20","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S0031-9384(02)00918-6","volume":"77","author":"AR Caggiula","year":"2002","unstructured":"Caggiula AR, Donny EC, Chaudhri N, Perkins KA, Evans-Martin FF, Sved AF (2002a) Importance of nonpharmacological factors in nicotine self-administration. Physiol Behav 77(4\u20135):683\u2013687. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieveanddb=PubMedanddopt=Citationandlist_uids=12527019","journal-title":"Physiol Behav"},{"issue":"2","key":"392_CR21","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s00213-002-1156-5","volume":"163","author":"AR Caggiula","year":"2002","unstructured":"Caggiula AR, Donny EC, White AR, Chaudhri N, Booth S, Gharib MA et al (2002b) Environmental stimuli promote the acquisition of nicotine self-administration in rats. Psychopharmacology (Berl) 163(2):230\u2013237. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieveanddb=PubMedanddopt=Citationandlist_uids=12202970","journal-title":"Psychopharmacology (Berl)"},{"key":"392_CR22","doi-asserted-by":"publisher","first-page":"Cd009329","DOI":"10.1002\/14651858.CD009329.pub2","volume":"5","author":"K Cahill","year":"2013","unstructured":"Cahill K, Stevens S, Perera R, Lancaster T (2013) Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev 5:Cd009329. https:\/\/doi.org\/10.1002\/14651858.CD009329.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"392_CR23","doi-asserted-by":"publisher","first-page":"e011045","DOI":"10.1136\/bmjopen-2016-011045","volume":"6","author":"M Chaiton","year":"2016","unstructured":"Chaiton M, Diemert L, Cohen JE, Bondy SJ, Selby P, Philipneri A, Schwartz R (2016) Estimating the number of quit attempts it takes to quit smoking successfully in a longitudinal cohort of smokers. BMJ Open 6(6):e011045. https:\/\/doi.org\/10.1136\/bmjopen-2016-011045","journal-title":"BMJ Open"},{"issue":"1\u20132","key":"392_CR24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/s0006-8993(03)02522-8","volume":"972","author":"YC Chiang","year":"2003","unstructured":"Chiang YC, Chen PC, Chen JC (2003) D(3) dopamine receptors are down-regulated in amphetamine sensitized rats and their putative antagonists modulate the locomotor sensitization to amphetamine. Brain Res 972(1\u20132):159\u2013167. https:\/\/doi.org\/10.1016\/s0006-8993(03)02522-8","journal-title":"Brain Res"},{"issue":"1","key":"392_CR25","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.1038\/s41598-020-60940-4","volume":"10","author":"CC Chukwueke","year":"2020","unstructured":"Chukwueke CC, Kowalczyk WJ, Di Ciano P, Gendy M, Taylor R, Heishman SJ, Le Foll B (2020) Exploring the role of the Ser9Gly (rs6280) dopamine D3 receptor polymorphism in nicotine reinforcement and cue-elicited craving. Sci Rep 10(1):4085. https:\/\/doi.org\/10.1038\/s41598-020-60940-4","journal-title":"Sci Rep"},{"issue":"1","key":"392_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/s0306-4522(98)00088-8","volume":"87","author":"JA Court","year":"1998","unstructured":"Court JA, Lloyd S, Thomas N, Piggott MA, Marshall EF, Morris CM et al (1998) Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use. Neuroscience 87(1):63\u201378. https:\/\/doi.org\/10.1016\/s0306-4522(98)00088-8","journal-title":"Neuroscience"},{"issue":"45","key":"392_CR27","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.15585\/mmwr.mm6845a2","volume":"68","author":"MR Creamer","year":"2019","unstructured":"Creamer MR, Wang TW, Babb S, Cullen KA, Day H, Willis G et al (2019) Tobacco product use and cessation indicators among adults - United States, 2018. MMWR Morb Mortal Wkly Rep 68(45):1013\u20131019. https:\/\/doi.org\/10.15585\/mmwr.mm6845a2","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"392_CR28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/14622200310001656858","volume":"6","author":"C Czermak","year":"2004","unstructured":"Czermak C, Lehofer M, Wagner EM, Prietl B, Gorkiewicz G, Lemonis L et al (2004) Reduced dopamine D3 receptor expression in blood lymphocytes of smokers is negatively correlated with daily number of smoked cigarettes: a peripheral correlate of dopaminergic alterations in smokers. Nicotine Tob Res 6(1):49\u201354. https:\/\/doi.org\/10.1080\/14622200310001656858","journal-title":"Nicotine Tob Res"},{"issue":"3","key":"392_CR29","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1046\/j.1460-9568.1998.00125.x","volume":"10","author":"P Di Ciano","year":"1998","unstructured":"Di Ciano P, Blaha CD, Phillips AG (1998a) Conditioned changes in dopamine oxidation currents in the nucleus accumbens of rats by stimuli paired with self-administration or yoked-administration of d-amphetamine. Eur J Neurosci 10(3):1121\u20131127. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieveanddb=PubMedanddopt=Citationandlist_uids=9753180","journal-title":"Eur J Neurosci"},{"issue":"3","key":"392_CR30","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1046\/j.1460-9568.1998.00124.x","volume":"10","author":"P Di Ciano","year":"1998","unstructured":"Di Ciano P, Blaha CD, Phillips AG (1998b) The relation between dopamine oxidation currents in the nucleus accumbens and conditioned increases in motor activity in rats following repeated administration of d-amphetamine or cocaine. Eur J Neurosci 10(3):1113\u20131120. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieveanddb=PubMedanddopt=Citationandlist_uids=9753179","journal-title":"Eur J Neurosci"},{"issue":"23","key":"392_CR31","doi-asserted-by":"publisher","first-page":"8677","DOI":"10.1523\/jneurosci.20-23-08677.2000","volume":"20","author":"J Diaz","year":"2000","unstructured":"Diaz J, Pilon C, Le Foll B, Gros C, Triller A, Schwartz JC, Sokoloff P (2000) Dopamine D3 receptors expressed by all mesencephalic dopamine neurons. J Neurosci 20(23):8677\u20138684. https:\/\/doi.org\/10.1523\/jneurosci.20-23-08677.2000","journal-title":"J Neurosci"},{"issue":"1\u20132","key":"392_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00213-003-1470-6","volume":"168","author":"DH Epstein","year":"2003","unstructured":"Epstein DH, Preston KL (2003) The reinstatement model and relapse prevention: a clinical perspective. Psychopharmacology (Berl) 168(1\u20132):31\u201341. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieveanddb=PubMedanddopt=Citationandlist_uids=12721778","journal-title":"Psychopharmacology (Berl)"},{"issue":"7","key":"392_CR33","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/npp.2014.18","volume":"39","author":"D Erritzoe","year":"2014","unstructured":"Erritzoe D, Tziortzi A, Bargiela D, Colasanti A, Searle GE, Gunn RN et al (2014) In vivo imaging of cerebral dopamine D3 receptors in alcoholism. Neuropsychopharmacology 39(7):1703\u20131712. https:\/\/doi.org\/10.1038\/npp.2014.18","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"392_CR34","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1176\/appi.ajp.2007.07020352","volume":"165","author":"C Fehr","year":"2008","unstructured":"Fehr C, Yakushev I, Hohmann N, Buchholz HG, Landvogt C, Deckers H et al (2008) Association of low striatal dopamine d2 receptor availability with nicotine dependence similar to that seen with other drugs of abuse. Am J Psychiatry 165(4):507\u2013514. https:\/\/doi.org\/10.1176\/appi.ajp.2007.07020352","journal-title":"Am J Psychiatry"},{"issue":"2","key":"392_CR35","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/bjp.2008.51","volume":"154","author":"MW Feltenstein","year":"2008","unstructured":"Feltenstein MW, See RE (2008) The neurocircuitry of addiction: an overview. Br J Pharmacol 154(2):261\u2013274. https:\/\/doi.org\/10.1038\/bjp.2008.51","journal-title":"Br J Pharmacol"},{"issue":"1\u20133","key":"392_CR36","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.drugalcdep.2012.10.016","volume":"130","author":"TP Freeman","year":"2013","unstructured":"Freeman TP, Morgan CJ, Brandner B, Almahdi B, Curran HV (2013) Dopaminergic involvement in effort-based but not impulsive reward processing in smokers. Drug Alcohol Depend 130(1\u20133):109\u2013114. https:\/\/doi.org\/10.1016\/j.drugalcdep.2012.10.016","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"392_CR37","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/scan\/nsu026","volume":"10","author":"TP Freeman","year":"2015","unstructured":"Freeman TP, Das RK, Kamboj SK, Curran HV (2015) Dopamine, urges to smoke, and the relative salience of drug versus non-drug reward. Soc Cogn Affect Neurosci 10(1):85\u201392. https:\/\/doi.org\/10.1093\/scan\/nsu026","journal-title":"Soc Cogn Affect Neurosci"},{"issue":"4","key":"392_CR38","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/npp.2013.286","volume":"39","author":"JD Gallezot","year":"2014","unstructured":"Gallezot JD, Kloczynski T, Weinzimmer D, Labaree D, Zheng MQ, Lim K et al (2014) Imaging nicotine- and amphetamine-induced dopamine release in rhesus monkeys with [(11)C]PHNO vs [(11)C]raclopride PET. Neuropsychopharmacology 39(4):866\u2013874. https:\/\/doi.org\/10.1038\/npp.2013.286","journal-title":"Neuropsychopharmacology"},{"issue":"13","key":"392_CR39","doi-asserted-by":"publisher","first-page":"5619","DOI":"10.1523\/jneurosci.22-13-05619.2002","volume":"22","author":"SB Glickstein","year":"2002","unstructured":"Glickstein SB, Hof PR, Schmauss C (2002) Mice lacking dopamine D2 and D3 receptors have spatial working memory deficits. J Neurosci 22(13):5619\u20135629. https:\/\/doi.org\/10.1523\/jneurosci.22-13-05619.2002","journal-title":"J Neurosci"},{"issue":"7","key":"392_CR40","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1093\/cercor\/bhh202","volume":"15","author":"SB Glickstein","year":"2005","unstructured":"Glickstein SB, Desteno DA, Hof PR, Schmauss C (2005) Mice lacking dopamine D2 and D3 receptors exhibit differential activation of prefrontal cortical neurons during tasks requiring attention. Cereb Cortex 15(7):1016\u20131024. https:\/\/doi.org\/10.1093\/cercor\/bhh202","journal-title":"Cereb Cortex"},{"issue":"1","key":"392_CR41","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1136\/tobaccocontrol-2016-053305","volume":"27","author":"M Goodchild","year":"2018","unstructured":"Goodchild M, Nargis N, Tursan d'Espaignet E (2018) Global economic cost of smoking-attributable diseases. Tob Control 27(1):58\u201364. https:\/\/doi.org\/10.1136\/tobaccocontrol-2016-053305","journal-title":"Tob Control"},{"issue":"1","key":"392_CR42","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S0893-133X(98)00066-9","volume":"20","author":"EV Gurevich","year":"1999","unstructured":"Gurevich EV, Joyce JN (1999) Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons. Neuropsychopharmacology 20(1):60\u201380. https:\/\/doi.org\/10.1016\/S0893-133X(98)00066-9","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"392_CR43","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.pbb.2004.04.026","volume":"78","author":"SB Harrod","year":"2004","unstructured":"Harrod SB, Mactutus CF, Bennett K, Hasselrot U, Wu G, Welch M, Booze RM (2004) Sex differences and repeated intravenous nicotine: behavioral sensitization and dopamine receptors. Pharmacol Biochem Behav 78(3):581\u2013592. https:\/\/doi.org\/10.1016\/j.pbb.2004.04.026","journal-title":"Pharmacol Biochem Behav"},{"issue":"1\u20132","key":"392_CR44","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/s0006-8993(97)01135-9","volume":"779","author":"BE Hildebrand","year":"1998","unstructured":"Hildebrand BE, Nomikos GG, Hertel P, Schilstr\u00f6m B, Svensson TH (1998) Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome. Brain Res 779(1\u20132):214\u2013225. https:\/\/doi.org\/10.1016\/s0006-8993(97)01135-9","journal-title":"Brain Res"},{"issue":"7","key":"392_CR45","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1002\/ajmg.b.30731","volume":"147b","author":"W Huang","year":"2008","unstructured":"Huang W, Payne TJ, Ma JZ, Li MD (2008) A functional polymorphism, rs6280, in DRD3 is significantly associated with nicotine dependence in European-American smokers. Am J Med Genet B Neuropsychiatr Genet 147b(7):1109\u20131115. https:\/\/doi.org\/10.1002\/ajmg.b.30731","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"1","key":"392_CR46","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1360-0443.2004.00540.x","volume":"99","author":"JR Hughes","year":"2004","unstructured":"Hughes JR, Keely J, Naud S (2004) Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction 99(1):29\u201338. https:\/\/doi.org\/10.1111\/j.1360-0443.2004.00540.x","journal-title":"Addiction"},{"issue":"19","key":"392_CR47","doi-asserted-by":"publisher","first-page":"7489","DOI":"10.1523\/JNEUROSCI.20-19-07489.2000","volume":"20","author":"R Ito","year":"2000","unstructured":"Ito R, Dalley JW, Howes SR, Robbins TW, Everitt BJ (2000) Dissociation in conditioned dopamine release in the nucleus accumbens core and shell in response to cocaine cues and during cocaine-seeking behavior in rats. J Neurosci 20(19):7489\u20137495. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieveanddb=PubMedanddopt=Citationandlist_uids=11007908","journal-title":"J Neurosci"},{"issue":"14","key":"392_CR48","doi-asserted-by":"publisher","first-page":"6247","DOI":"10.1523\/JNEUROSCI.22-14-06247.2002","volume":"22","author":"R Ito","year":"2002","unstructured":"Ito R, Dalley JW, Robbins TW, Everitt BJ (2002) Dopamine release in the dorsal striatum during cocaine-seeking behavior under the control of a drug-associated cue. J Neurosci 22(14):6247\u20136253. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/htbin-post\/Entrez\/query?db=mandform=6anddopt=randuid=12122083","journal-title":"J Neurosci"},{"issue":"11","key":"392_CR49","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/s0028-3908(96)00100-1","volume":"35","author":"M Jaber","year":"1996","unstructured":"Jaber M, Robinson SW, Missale C, Caron MG (1996) Dopamine receptors and brain function. Neuropharmacology 35(11):1503\u20131519. https:\/\/doi.org\/10.1016\/s0028-3908(96)00100-1","journal-title":"Neuropharmacology"},{"issue":"5","key":"392_CR50","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/add.14549","volume":"114","author":"SE Jackson","year":"2019","unstructured":"Jackson SE, McGowan JA, Ubhi HK, Proudfoot H, Shahab L, Brown J, West R (2019) Modelling continuous abstinence rates over time from clinical trials of pharmacological interventions for smoking cessation. Addiction 114(5):787\u2013797. https:\/\/doi.org\/10.1111\/add.14549","journal-title":"Addiction"},{"issue":"4","key":"392_CR51","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJMsa1211128","volume":"368","author":"P Jha","year":"2013","unstructured":"Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M, Anderson RN et al (2013) 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med 368(4):341\u2013350. https:\/\/doi.org\/10.1056\/NEJMsa1211128","journal-title":"N Engl J Med"},{"issue":"5\u20136","key":"392_CR52","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/FBP.0b013e3283641c3d","volume":"24","author":"JD Jones","year":"2013","unstructured":"Jones JD, Comer SD (2013) A review of human drug self-administration procedures. Behav Pharmacol 24(5\u20136):384\u2013395. https:\/\/doi.org\/10.1097\/FBP.0b013e3283641c3d","journal-title":"Behav Pharmacol"},{"issue":"2","key":"392_CR53","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1017\/S1461145709991064","volume":"13","author":"MA Khaled","year":"2010","unstructured":"Khaled MA, Farid Araki K, Li B, Coen KM, Marinelli PW, Varga J et al (2010) The selective dopamine D3 receptor antagonist SB 277011-A, but not the partial agonist BP 897, blocks cue-induced reinstatement of nicotine-seeking. Int J Neuropsychopharmacol 13(2):181\u2013190. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieveanddb=PubMedanddopt=Citationandlist_uids=19995481","journal-title":"Int J Neuropsychopharmacol"},{"issue":"6","key":"392_CR54","doi-asserted-by":"publisher","first-page":"e98199","DOI":"10.1371\/journal.pone.0098199","volume":"9","author":"T Korhonen","year":"2014","unstructured":"Korhonen T, Loukola A, Wedenoja J, Nyman E, Latvala A, Broms U et al (2014) Role of nicotine dependence in the association between the dopamine receptor gene DRD3 and major depressive disorder. PLoS One 9(6):e98199. https:\/\/doi.org\/10.1371\/journal.pone.0098199","journal-title":"PLoS One"},{"issue":"5","key":"392_CR55","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1017\/s1461145710000696","volume":"16","author":"V Kushnir","year":"2013","unstructured":"Kushnir V, Menon M, Balducci XL, Selby P, Busto U, Zawertailo L (2013) Enhanced smoking cue salience associated with depression severity in nicotine-dependent individuals: a preliminary fMRI study. Int J Neuropsychopharmacol 16(5):997\u20131008. https:\/\/doi.org\/10.1017\/s1461145710000696","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1","key":"392_CR56","first-page":"47","volume":"33","author":"HY Lane","year":"2008","unstructured":"Lane HY, Liu YC, Huang CL, Hsieh CL, Chang YL, Chang L et al (2008) Prefrontal executive function and D1, D3, 5-HT2A and 5-HT6 receptor gene variations in healthy adults. J Psychiatry Neurosci 33(1):47\u201353","journal-title":"J Psychiatry Neurosci"},{"issue":"7","key":"392_CR57","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1093\/ntr\/ntx159","volume":"20","author":"W Lawn","year":"2018","unstructured":"Lawn W, Freeman TP, East K, Gaule A, Aston ER, Bloomfield MAP et al (2018) The acute effects of a dopamine D3 receptor preferring agonist on motivation for cigarettes in dependent and occasional cigarette smokers. Nicotine Tob Res 20(7):800\u2013809. https:\/\/doi.org\/10.1093\/ntr\/ntx159","journal-title":"Nicotine Tob Res"},{"issue":"2","key":"392_CR58","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/s0924-9338(00)00219-4","volume":"15","author":"B Le Foll","year":"2000","unstructured":"Le Foll B, Schwartz JC, Sokoloff P (2000) Dopamine D3 receptor agents as potential new medications for drug addiction. Eur Psychiatry 15(2):140\u2013146. https:\/\/doi.org\/10.1016\/s0924-9338(00)00219-4","journal-title":"Eur Psychiatry"},{"issue":"3","key":"392_CR59","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/syn.10170","volume":"47","author":"B Le Foll","year":"2003","unstructured":"Le Foll B, Diaz J, Sokoloff P (2003a) Increased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats. Synapse 47(3):176\u2013183. https:\/\/doi.org\/10.1002\/syn.10170","journal-title":"Synapse"},{"issue":"2","key":"392_CR60","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/sj.mp.4001202","volume":"8","author":"B Le Foll","year":"2003","unstructured":"Le Foll B, Schwartz JC, Sokoloff P (2003b) Disruption of nicotine conditioning by dopamine D(3) receptor ligands. Mol Psychiatry 8(2):225\u2013230. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieveanddb=PubMedanddopt=Citationandlist_uids=12610655","journal-title":"Mol Psychiatry"},{"issue":"4","key":"392_CR61","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.neuropharm.2005.04.022","volume":"49","author":"B Le Foll","year":"2005","unstructured":"Le Foll B, Goldberg SR, Sokoloff P (2005a) The dopamine D3 receptor and drug dependence: effects on reward or beyond? Neuropharmacology 49(4):525\u2013541. https:\/\/doi.org\/10.1016\/j.neuropharm.2005.04.022","journal-title":"Neuropharmacology"},{"issue":"4","key":"392_CR62","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/sj.npp.1300622","volume":"30","author":"B Le Foll","year":"2005","unstructured":"Le Foll B, Sokoloff P, Stark H, Goldberg SR (2005b) Dopamine D3 receptor ligands block nicotine-induced conditioned place preferences through a mechanism that does not involve discriminative-stimulus or antidepressant-like effects. Neuropsychopharmacology 30(4):720\u2013730. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieveanddb=PubMedanddopt=Citationandlist_uids=15562293","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"392_CR63","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/npp.2013.209","volume":"39","author":"B Le Foll","year":"2014","unstructured":"Le Foll B, Guranda M, Wilson AA, Houle S, Rusjan PM, Wing VC et al (2014a) Elevation of dopamine induced by cigarette smoking: novel insights from a [11C]\u2212+-PHNO PET study in humans. Neuropsychopharmacology 39(2):415\u2013424. https:\/\/doi.org\/10.1038\/npp.2013.209","journal-title":"Neuropsychopharmacology"},{"key":"392_CR64","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3389\/fphar.2014.00161","volume":"5","author":"B Le Foll","year":"2014","unstructured":"Le Foll B, Wilson AA, Graff A, Boileau I, Di Ciano P (2014b) Recent methods for measuring dopamine D3 receptor occupancy in vivo: importance for drug development. Front Pharmacol 5:161. https:\/\/doi.org\/10.3389\/fphar.2014.00161","journal-title":"Front Pharmacol"},{"issue":"1","key":"392_CR65","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11065-019-09402-x","volume":"29","author":"RSC Lee","year":"2019","unstructured":"Lee RSC, Hoppenbrouwers S, Franken I (2019) A systematic meta-review of impulsivity and compulsivity in addictive behaviors. Neuropsychol Rev 29(1):14\u201326. https:\/\/doi.org\/10.1007\/s11065-019-09402-x","journal-title":"Neuropsychol Rev"},{"key":"392_CR66","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1126\/science.278.5335.45","volume":"278","author":"AI Leshner","year":"1997","unstructured":"Leshner AI (1997) Addiction is a brain disease, and it matters. Science 278:45\u201347","journal-title":"Science"},{"issue":"6","key":"392_CR67","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.tips.2014.04.002","volume":"35","author":"M Leyton","year":"2014","unstructured":"Leyton M, Vezina P (2014) Dopamine ups and downs in vulnerability to addictions: a neurodevelopmental model. Trends Pharmacol Sci 35(6):268\u2013276. https:\/\/doi.org\/10.1016\/j.tips.2014.04.002","journal-title":"Trends Pharmacol Sci"},{"issue":"10","key":"392_CR68","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.euroneuro.2012.10.017","volume":"23","author":"M Luijten","year":"2013","unstructured":"Luijten M, Veltman DJ, Hester R, Smits M, Nijs IM, Pepplinkhuizen L, Franken IH (2013) The role of dopamine in inhibitory control in smokers and non-smokers: a pharmacological fMRI study. Eur Neuropsychopharmacol 23(10):1247\u20131256. https:\/\/doi.org\/10.1016\/j.euroneuro.2012.10.017","journal-title":"Eur Neuropsychopharmacol"},{"issue":"5","key":"392_CR69","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/ntr\/ntv233","volume":"18","author":"J Mackillop","year":"2016","unstructured":"Mackillop J, Murphy CM, Martin RA, Stojek M, Tidey JW, Colby SM, Rohsenow DJ (2016) Predictive validity of a cigarette purchase task in a randomized controlled trial of contingent vouchers for smoking in individuals with substance use disorders. Nicotine Tob Res 18(5):531\u2013537. https:\/\/doi.org\/10.1093\/ntr\/ntv233","journal-title":"Nicotine Tob Res"},{"key":"392_CR70","doi-asserted-by":"publisher","unstructured":"Makate M, Whetton S, Tait RJ, Dey T, Scollo M, Banks E et al (2019) Tobacco cost of illness studies: a systematic review. Nicotine Tob Res. https:\/\/doi.org\/10.1093\/ntr\/ntz038","DOI":"10.1093\/ntr\/ntz038"},{"issue":"2","key":"392_CR71","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/sj.npp.1300287","volume":"29","author":"S Marenco","year":"2004","unstructured":"Marenco S, Carson RE, Berman KF, Herscovitch P, Weinberger DR (2004) Nicotine-induced dopamine release in primates measured with [11C]raclopride PET. Neuropsychopharmacology 29(2):259\u2013268. https:\/\/doi.org\/10.1038\/sj.npp.1300287","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"392_CR72","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1038\/sj.npp.1300420","volume":"29","author":"D Martinez","year":"2004","unstructured":"Martinez D, Broft A, Foltin RW, Slifstein M, Hwang DR, Huang Y et al (2004) Cocaine dependence and d2 receptor availability in the functional subdivisions of the striatum: relationship with cocaine-seeking behavior. Neuropsychopharmacology 29(6):1190\u20131202. https:\/\/doi.org\/10.1038\/sj.npp.1300420","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"392_CR73","first-page":"5","volume":"2","author":"DC Mash","year":"1997","unstructured":"Mash DC (1997) D3 receptor binding in human brain during cocaine overdose. Mol Psychiatry 2(1):5\u20136. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9154208","journal-title":"Mol Psychiatry"},{"key":"392_CR74","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/978-3-319-13482-6_4","volume":"24","author":"I McLaughlin","year":"2015","unstructured":"McLaughlin I, Dani JA, De Biasi M (2015) Nicotine withdrawal. Curr Top Behav Neurosci 24:99\u2013123. https:\/\/doi.org\/10.1007\/978-3-319-13482-6_4","journal-title":"Curr Top Behav Neurosci"},{"key":"392_CR75","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/s0074-7742(05)63005-x","volume":"63","author":"M Melis","year":"2005","unstructured":"Melis M, Spiga S, Diana M (2005) The dopamine hypothesis of drug addiction: hypodopaminergic state. Int Rev Neurobiol 63:101\u2013154. https:\/\/doi.org\/10.1016\/s0074-7742(05)63005-x","journal-title":"Int Rev Neurobiol"},{"issue":"21","key":"392_CR76","doi-asserted-by":"publisher","first-page":"5076","DOI":"10.1021\/jm0705612","volume":"50","author":"F Micheli","year":"2007","unstructured":"Micheli F, Bonanomi G, Blaney FE, Braggio S, Capelli AM, Checchia A et al (2007) 1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists. J Med Chem 50(21):5076\u20135089. https:\/\/doi.org\/10.1021\/jm0705612","journal-title":"J Med Chem"},{"issue":"3","key":"392_CR77","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2515\/therapie:2008041","volume":"63","author":"MJ Millan","year":"2008","unstructured":"Millan MJ, Brocco M (2008) Cognitive impairment in schizophrenia: a review of developmental and genetic models, and pro-cognitive profile of the optimised D(3) > D(2) antagonist, S33138. Therapie 63(3):187\u2013229. https:\/\/doi.org\/10.2515\/therapie:2008041","journal-title":"Therapie"},{"issue":"8","key":"392_CR78","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1017\/s1461145710000775","volume":"13","author":"MJ Millan","year":"2010","unstructured":"Millan MJ, Buccafusco JJ, Loiseau F, Watson DJ, Decamp E, Fone KC et al (2010) The dopamine D3 receptor antagonist, S33138, counters cognitive impairment in a range of rodent and primate procedures. Int J Neuropsychopharmacol 13(8):1035\u20131051. https:\/\/doi.org\/10.1017\/s1461145710000775","journal-title":"Int J Neuropsychopharmacol"},{"issue":"2","key":"392_CR79","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/npp.2012.171","volume":"38","author":"M Mugnaini","year":"2013","unstructured":"Mugnaini M, Iavarone L, Cavallini P, Griffante C, Oliosi B, Savoia C et al (2013) Occupancy of brain dopamine d(3) receptors and drug craving: a translational approach. Neuropsychopharmacology 38(2):302\u2013312. https:\/\/doi.org\/10.1038\/npp.2012.171","journal-title":"Neuropsychopharmacology"},{"issue":"23","key":"392_CR80","doi-asserted-by":"publisher","first-page":"11271","DOI":"10.1073\/pnas.91.23.11271","volume":"91","author":"AM Murray","year":"1994","unstructured":"Murray AM, Ryoo HL, Gurevich E, Joyce JN (1994) Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain. Proc Natl Acad Sci U S A 91(23):11271\u201311275. https:\/\/doi.org\/10.1073\/pnas.91.23.11271","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"392_CR81","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.euroneuro.2013.05.006","volume":"23","author":"S Nakajima","year":"2013","unstructured":"Nakajima S, Gerretsen P, Takeuchi H, Caravaggio F, Chow T, Le Foll B et al (2013) The potential role of dopamine D3 receptor neurotransmission in cognition. Eur Neuropsychopharmacol 23(8):799\u2013813. https:\/\/doi.org\/10.1016\/j.euroneuro.2013.05.006","journal-title":"Eur Neuropsychopharmacol"},{"issue":"7","key":"392_CR82","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/syn.20325","volume":"60","author":"R Narendran","year":"2006","unstructured":"Narendran R, Slifstein M, Guillin O, Hwang Y, Hwang DR, Scher E et al (2006) Dopamine (D2\/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo. Synapse 60(7):485\u2013495. https:\/\/doi.org\/10.1002\/syn.20325","journal-title":"Synapse"},{"issue":"2","key":"392_CR83","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1017\/s1461145711001052","volume":"15","author":"PJ Nathan","year":"2012","unstructured":"Nathan PJ, O'Neill BV, Mogg K, Bradley BP, Beaver J, Bani M et al (2012) The effects of the dopamine D3 receptor antagonist GSK598809 on attentional bias to palatable food cues in overweight and obese subjects. Int J Neuropsychopharmacol 15(2):149\u2013161. https:\/\/doi.org\/10.1017\/s1461145711001052","journal-title":"Int J Neuropsychopharmacol"},{"issue":"2","key":"392_CR84","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/syn.20713","volume":"64","author":"LA Natividad","year":"2010","unstructured":"Natividad LA, Tejeda HA, Torres OV, O'Dell LE (2010) Nicotine withdrawal produces a decrease in extracellular levels of dopamine in the nucleus accumbens that is lower in adolescent versus adult male rats. Synapse 64(2):136\u2013145. https:\/\/doi.org\/10.1002\/syn.20713","journal-title":"Synapse"},{"issue":"8","key":"392_CR85","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1038\/sj.npp.1300456","volume":"29","author":"JL Neisewander","year":"2004","unstructured":"Neisewander JL, Fuchs RA, Tran-Nguyen LT, Weber SM, Coffey GP, Joyce JN (2004) Increases in dopamine D3 receptor binding in rats receiving a cocaine challenge at various time points after cocaine self-administration: implications for cocaine-seeking behavior. Neuropsychopharmacology 29(8):1479\u20131487. https:\/\/doi.org\/10.1038\/sj.npp.1300456","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"392_CR86","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1469-1809.2010.00578.x","volume":"74","author":"G Novak","year":"2010","unstructured":"Novak G, LeBlanc M, Zai C, Shaikh S, Renou J, DeLuca V et al (2010) Association of polymorphisms in the BDNF, DRD1 and DRD3 genes with tobacco smoking in schizophrenia. Ann Hum Genet 74(4):291\u2013298. https:\/\/doi.org\/10.1111\/j.1469-1809.2010.00578.x","journal-title":"Ann Hum Genet"},{"issue":"4","key":"392_CR87","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.pbb.2011.05.010","volume":"99","author":"Y Ohmura","year":"2011","unstructured":"Ohmura Y, Jutkiewicz EM, Zhang A, Domino EF (2011) Dopamine D1\/5 and D2\/3 agonists differentially attenuate somatic signs of nicotine withdrawal in rats. Pharmacol Biochem Behav 99(4):552\u2013556. https:\/\/doi.org\/10.1016\/j.pbb.2011.05.010","journal-title":"Pharmacol Biochem Behav"},{"issue":"5","key":"392_CR88","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1017\/S1461145706006560","volume":"9","author":"AC Pak","year":"2006","unstructured":"Pak AC, Ashby CR Jr, Heidbreder CA, Pilla M, Gilbert J, Xi ZX, Gardner EL (2006) The selective dopamine D3 receptor antagonist SB-277011A reduces nicotine-enhanced brain reward and nicotine-paired environmental cue functions. Int J Neuropsychopharmacol 9(5):585\u2013602. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieveanddb=PubMedanddopt=Citationandlist_uids=16942635","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1","key":"392_CR89","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.drugalcdep.2009.07.020","volume":"106","author":"F Patterson","year":"2010","unstructured":"Patterson F, Jepson C, Loughead J, Perkins K, Strasser AA, Siegel S et al (2010) Working memory deficits predict short-term smoking resumption following brief abstinence. Drug Alcohol Depend 106(1):61\u201364. https:\/\/doi.org\/10.1016\/j.drugalcdep.2009.07.020","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"392_CR90","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/npp.2013.192","volume":"39","author":"DE Payer","year":"2014","unstructured":"Payer DE, Behzadi A, Kish SJ, Houle S, Wilson AA, Rusjan PM et al (2014) Heightened D3 dopamine receptor levels in cocaine dependence and contributions to the addiction behavioral phenotype: a positron emission tomography study with [11C]\u2212+-PHNO. Neuropsychopharmacology 39(2):311\u2013318. https:\/\/doi.org\/10.1038\/npp.2013.192","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"392_CR91","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1111\/add.14234","volume":"113","author":"A Peacock","year":"2018","unstructured":"Peacock A, Leung J, Larney S, Colledge S, Hickman M, Rehm J et al (2018) Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction 113(10):1905\u20131926. https:\/\/doi.org\/10.1111\/add.14234","journal-title":"Addiction"},{"issue":"6742","key":"392_CR92","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/22560","volume":"400","author":"M Pilla","year":"1999","unstructured":"Pilla M, Perachon S, Sautel F, Garrido F, Mann A, Wermuth CG et al (1999) Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist. Nature 400(6742):371\u2013375. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieveanddb=PubMedanddopt=Citationandlist_uids=10432116","journal-title":"Nature"},{"issue":"4","key":"392_CR93","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s00213-010-1975-8","volume":"212","author":"J Powell","year":"2010","unstructured":"Powell J, Dawkins L, West R, Powell J, Pickering A (2010) Relapse to smoking during unaided cessation: clinical, cognitive and motivational predictors. Psychopharmacology (Berl) 212(4):537\u2013549. https:\/\/doi.org\/10.1007\/s00213-010-1975-8","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"392_CR94","doi-asserted-by":"publisher","first-page":"5562","DOI":"10.1038\/s41467-020-19265-z","volume":"11","author":"BC Quach","year":"2020","unstructured":"Quach BC, Bray MJ, Gaddis NC, Liu M, Palviainen T, Minica CC et al (2020) Expanding the genetic architecture of nicotine dependence and its shared genetics with multiple traits. Nat Commun 11(1):5562. https:\/\/doi.org\/10.1038\/s41467-020-19265-z","journal-title":"Nat Commun"},{"issue":"3","key":"392_CR95","first-page":"1154","volume":"294","author":"C Reavill","year":"2000","unstructured":"Reavill C, Taylor SG, Wood MD, Ashmeade T, Austin NE, Avenell KY et al (2000) Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist, SB-277011-A. J Pharmacol Exp Ther 294(3):1154\u20131165. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieveanddb=PubMedanddopt=Citationandlist_uids=10945872","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"392_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0165-0270(95)00153-0","volume":"66","author":"NR Richardson","year":"1996","unstructured":"Richardson NR, Roberts DC (1996) Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods 66(1):1\u201311. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8794935","journal-title":"J Neurosci Methods"},{"issue":"2","key":"392_CR97","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1037\/adb0000434","volume":"33","author":"JD Robinson","year":"2019","unstructured":"Robinson JD, Li L, Chen M, Lerman C, Tyndale RF, Schnoll RA et al (2019) Evaluating the temporal relationships between withdrawal symptoms and smoking relapse. Psychol Addict Behav 33(2):105\u2013116. https:\/\/doi.org\/10.1037\/adb0000434","journal-title":"Psychol Addict Behav"},{"issue":"5","key":"392_CR98","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/add.14134","volume":"113","author":"LJ Rosen","year":"2018","unstructured":"Rosen LJ, Galili T, Kott J, Goodman M, Freedman LS (2018) Diminishing benefit of smoking cessation medications during the first year: a meta-analysis of randomized controlled trials. Addiction 113(5):805\u2013816. https:\/\/doi.org\/10.1111\/add.14134","journal-title":"Addiction"},{"issue":"2\u20133","key":"392_CR99","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ejphar.2007.01.004","volume":"559","author":"JT Ross","year":"2007","unstructured":"Ross JT, Corrigall WA, Heidbreder CA, LeSage MG (2007) Effects of the selective dopamine D3 receptor antagonist SB-277011A on the reinforcing effects of nicotine as measured by a progressive-ratio schedule in rats. Eur J Pharmacol 559(2\u20133):173\u2013179. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieveanddb=PubMedanddopt=Citationandlist_uids=17303116","journal-title":"Eur J Pharmacol"},{"key":"392_CR100","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.pnpbp.2015.08.006","volume":"64","author":"P Sabioni","year":"2016","unstructured":"Sabioni P, Di Ciano P, Le Foll B (2016) Effect of a D3 receptor antagonist on context-induced reinstatement of nicotine seeking. Prog Neuropsychopharmacol Biol Psychiatry 64:149\u2013154. https:\/\/doi.org\/10.1016\/j.pnpbp.2015.08.006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"392_CR101","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1300\/J069v20n03_06","volume":"20","author":"KW Sax","year":"2001","unstructured":"Sax KW, Strakowski SM (2001) Behavioral sensitization in humans. J Addict Dis 20(3):55\u201365. https:\/\/doi.org\/10.1300\/J069v20n03_06","journal-title":"J Addict Dis"},{"issue":"2","key":"392_CR102","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0169-328X(97)00025-9","volume":"45","author":"DM Segal","year":"1997","unstructured":"Segal DM, Moraes CT, Mash DC (1997) Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities. Brain Res Mol Brain Res 45(2):335\u2013339. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9149110","journal-title":"Brain Res Mol Brain Res"},{"issue":"2","key":"392_CR103","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/0165-6147(92)90025-2","volume":"13","author":"DR Sibley","year":"1992","unstructured":"Sibley DR, Monsma FJ Jr (1992) Molecular biology of dopamine receptors. Trends Pharmacol Sci 13(2):61\u201369. https:\/\/doi.org\/10.1016\/0165-6147(92)90025-2","journal-title":"Trends Pharmacol Sci"},{"key":"392_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2014.08.009","volume":"145","author":"JL Smith","year":"2014","unstructured":"Smith JL, Mattick RP, Jamadar SD, Iredale JM (2014) Deficits in behavioural inhibition in substance abuse and addiction: a meta-analysis. Drug Alcohol Depend 145:1\u201333. https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.08.009","journal-title":"Drug Alcohol Depend"},{"key":"392_CR105","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.bbr.2015.04.025","volume":"289","author":"LN Smith","year":"2015","unstructured":"Smith LN, Bachus SE, McDonald CG, Smith RF (2015) Role of the D3 dopamine receptor in nicotine sensitization. Behav Brain Res 289:92\u2013104. https:\/\/doi.org\/10.1016\/j.bbr.2015.04.025","journal-title":"Behav Brain Res"},{"issue":"1","key":"392_CR106","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.neuropharm.2012.06.021","volume":"64","author":"M Sofuoglu","year":"2013","unstructured":"Sofuoglu M, DeVito EE, Waters AJ, Carroll KM (2013) Cognitive enhancement as a treatment for drug addictions. Neuropharmacology 64(1):452\u2013463. https:\/\/doi.org\/10.1016\/j.neuropharm.2012.06.021","journal-title":"Neuropharmacology"},{"issue":"6289","key":"392_CR107","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/347146a0","volume":"347","author":"P Sokoloff","year":"1990","unstructured":"Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC (1990) Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347(6289):146\u2013151. https:\/\/doi.org\/10.1038\/347146a0","journal-title":"Nature"},{"issue":"3","key":"392_CR108","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/nprot.2006.167","volume":"1","author":"M Solinas","year":"2006","unstructured":"Solinas M, Panlilio LV, Justinova Z, Yasar S, Goldberg SR (2006) Using drug-discrimination techniques to study the abuse-related effects of psychoactive drugs in rats. Nat Protoc 1(3):1194\u20131206. https:\/\/doi.org\/10.1038\/nprot.2006.167","journal-title":"Nat Protoc"},{"issue":"19","key":"392_CR109","doi-asserted-by":"publisher","first-page":"6100","DOI":"10.1523\/JNEUROSCI.16-19-06100.1996","volume":"16","author":"JK Staley","year":"1996","unstructured":"Staley JK, Mash DC (1996) Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities. J Neurosci 16(19):6100\u20136106. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8815892","journal-title":"J Neurosci"},{"key":"392_CR110","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1744-9081-3-22","volume":"3","author":"TG Ton","year":"2007","unstructured":"Ton TG, Rossing MA, Bowen DJ, Srinouanprachan S, Wicklund K, Farin FM (2007) Genetic polymorphisms in dopamine-related genes and smoking cessation in women: a prospective cohort study. Behav Brain Funct 3:22. https:\/\/doi.org\/10.1186\/1744-9081-3-22","journal-title":"Behav Brain Funct"},{"issue":"6","key":"392_CR111","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0301-0082(98)00060-4","volume":"56","author":"TM Tzschentke","year":"1998","unstructured":"Tzschentke TM (1998) Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol 56(6):613\u2013672. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieveanddb=PubMedanddopt=Citationandlist_uids=9871940","journal-title":"Prog Neurobiol"},{"issue":"1","key":"392_CR112","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1369-1600.2007.00054.x","volume":"12","author":"DJ Vandenbergh","year":"2007","unstructured":"Vandenbergh DJ, O'Connor RJ, Grant MD, Jefferson AL, Vogler GP, Strasser AA, Kozlowski LT (2007) Dopamine receptor genes (DRD2, DRD3 and DRD4) and gene-gene interactions associated with smoking-related behaviors. Addict Biol 12(1):106\u2013116. https:\/\/doi.org\/10.1111\/j.1369-1600.2007.00054.x","journal-title":"Addict Biol"},{"issue":"13","key":"392_CR113","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1096\/fj.06-6110com","volume":"20","author":"V Vengeliene","year":"2006","unstructured":"Vengeliene V, Leonardi-Essmann F, Perreau-Lenz S, Gebicke-Haerter P, Drescher K, Gross G, Spanagel R (2006) The dopamine D3 receptor plays an essential role in alcohol-seeking and relapse. FASEB J 20(13):2223\u20132233. https:\/\/doi.org\/10.1096\/fj.06-6110com","journal-title":"FASEB J"},{"issue":"9","key":"392_CR114","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1111\/j.1530-0277.1996.tb05936.x","volume":"20","author":"ND Volkow","year":"1996","unstructured":"Volkow ND, Wang GJ, Fowler JS, Logan J, Hitzemann R, Ding YS et al (1996) Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alcohol Clin Exp Res 20(9):1594\u20131598","journal-title":"Alcohol Clin Exp Res"},{"issue":"6","key":"392_CR115","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/sj.mp.4001507","volume":"9","author":"ND Volkow","year":"2004","unstructured":"Volkow ND, Fowler JS, Wang GJ, Swanson JM (2004) Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol Psychiatry 9(6):557\u2013569. https:\/\/doi.org\/10.1038\/sj.mp.4001507","journal-title":"Mol Psychiatry"},{"issue":"Suppl 1","key":"392_CR116","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.neuropharm.2008.05.022","volume":"56","author":"ND Volkow","year":"2009","unstructured":"Volkow ND, Fowler JS, Wang GJ, Baler R, Telang F (2009) Imaging dopamine's role in drug abuse and addiction. Neuropharmacology 56(Suppl 1):3\u20138. https:\/\/doi.org\/10.1016\/j.neuropharm.2008.05.022","journal-title":"Neuropharmacology"},{"issue":"4","key":"392_CR117","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/BF00413156","volume":"6","author":"JR Weeks","year":"1964","unstructured":"Weeks JR, Collins RJ (1964) Factors affecting voluntary morphine intake in self-maintained addicted rats. Psychopharmacologia 6(4):267\u2013279. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieveanddb=PubMedanddopt=Citationandlist_uids=5890552","journal-title":"Psychopharmacologia"},{"issue":"5","key":"392_CR118","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.addbeh.2012.01.009","volume":"37","author":"J Wei","year":"2012","unstructured":"Wei J, Chu C, Wang Y, Yang Y, Wang Q, Li T et al (2012) Association study of 45 candidate genes in nicotine dependence in Han Chinese. Addict Behav 37(5):622\u2013626. https:\/\/doi.org\/10.1016\/j.addbeh.2012.01.009","journal-title":"Addict Behav"},{"issue":"2","key":"392_CR119","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1521-0391.2011.00203.x","volume":"21","author":"AH Weinberger","year":"2012","unstructured":"Weinberger AH, McKee SA, George TP (2012) Smoking cue reactivity in adult smokers with and without depression: a pilot study. Am J Addict 21(2):136\u2013144. https:\/\/doi.org\/10.1111\/j.1521-0391.2011.00203.x","journal-title":"Am J Addict"},{"issue":"12","key":"392_CR120","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1038\/npp.2017.131","volume":"42","author":"CE Wiers","year":"2017","unstructured":"Wiers CE, Cabrera EA, Tomasi D, Wong CT, Demiral \u015eB, Kim SW et al (2017) Striatal dopamine D2\/D3 receptor availability varies across smoking status. Neuropsychopharmacology 42(12):2325\u20132332. https:\/\/doi.org\/10.1038\/npp.2017.131","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"392_CR121","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1038\/npp.2014.327","volume":"40","author":"VC Wing","year":"2015","unstructured":"Wing VC, Payer DE, Houle S, George TP, Boileau I (2015) Measuring cigarette smoking-induced cortical dopamine release: a [11C]FLB-457 PET study. Neuropsychopharmacology 40(6):1417\u20131427. https:\/\/doi.org\/10.1038\/npp.2014.327","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"392_CR122","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1037\/0033-295X.94.4.469","volume":"94","author":"RA Wise","year":"1987","unstructured":"Wise RA, Bozarth MA (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94(4):469\u2013492. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieveanddb=PubMedanddopt=Citationandlist_uids=3317472","journal-title":"Psychol Rev"},{"key":"392_CR123","unstructured":"World Health Organization (2019) Tobacco Factsheet, updated 29 May 2019. Retrieved from Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/tobacco. Accessed June 2019"},{"issue":"3","key":"392_CR124","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.neulet.2010.06.071","volume":"481","author":"B Xing","year":"2010","unstructured":"Xing B, Meng X, Wei S, Li S (2010) Influence of dopamine D3 receptor knockout on age-related decline of spatial memory. Neurosci Lett 481(3):149\u2013153. https:\/\/doi.org\/10.1016\/j.neulet.2010.06.071","journal-title":"Neurosci Lett"},{"issue":"8","key":"392_CR125","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1038\/npp.2016.9","volume":"41","author":"FD Zeeb","year":"2016","unstructured":"Zeeb FD, Soko AD, Ji X, Fletcher PJ (2016) Low impulsive action, but not impulsive choice, predicts greater conditioned reinforcer salience and augmented nucleus Accumbens dopamine release. Neuropsychopharmacology 41(8):2091\u20132100. https:\/\/doi.org\/10.1038\/npp.2016.9","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"392_CR126","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.biopsych.2011.07.024","volume":"71","author":"L Zhang","year":"2012","unstructured":"Zhang L, Dong Y, Doyon WM, Dani JA (2012) Withdrawal from chronic nicotine exposure alters dopamine signaling dynamics in the nucleus accumbens. Biol Psychiatry 71(3):184\u2013191. https:\/\/doi.org\/10.1016\/j.biopsych.2011.07.024","journal-title":"Biol Psychiatry"}],"container-title":["Current Topics in Behavioral Neurosciences","Therapeutic Applications of Dopamine D3 Receptor Function"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/7854_2022_392","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T14:06:35Z","timestamp":1672927595000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/7854_2022_392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9783031230578","9783031230585"],"references-count":126,"URL":"https:\/\/doi.org\/10.1007\/7854_2022_392","relation":{},"ISSN":["1866-3370","1866-3389"],"issn-type":[{"type":"print","value":"1866-3370"},{"type":"electronic","value":"1866-3389"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"30 September 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"Dr. Bernard Le Foll has obtained funding from Pfizer Inc. (GRAND Awards, including salary support) for investigator-initiated projects. Dr. Le Foll has obtained funding from Indivior for a clinical trial sponsored by Indivior. Dr. Le Foll has in-kind donations of cannabis products from Aurora Cannabis Enterprises Inc. and study medication donations from Pfizer Inc. (varenicline for smoking cessation) and Bioprojet Pharma. He was also provided a coil for a transcranial magnetic stimulation (TMS) study from Brainsway. Dr. Le Foll has obtained industry funding from Canopy Growth Corporation (through research grants handled by the Centre for Addiction and Mental Health and the University of Toronto), Bioprojet Pharma, Alcohol Countermeasure Systems (ACS), Alkermes, and Universal Ibogaine. Lastly, Dr. Le Foll has received in-kind donations of nabiximols from GW Pharmaceuticals for the past studies funded by CIHR and NIH.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"He has participated in a session of a National Advisory Board Meeting (Emerging Trends BUP-XR) for Indivior Canada and has been a consultant for Shinogi. He is supported by CAMH, Waypoint Centre for Mental Health Care, a clinician-scientist award from the Department of Family and Community Medicine of the University of Toronto and a Chair in Addiction Psychiatry from the Department of Psychiatry of University of Toronto.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}